<SEC-DOCUMENT>0001292814-20-002666.txt : 20200721
<SEC-HEADER>0001292814-20-002666.hdr.sgml : 20200721
<ACCEPTANCE-DATETIME>20200721081757
ACCESSION NUMBER:		0001292814-20-002666
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20200930
FILED AS OF DATE:		20200721
DATE AS OF CHANGE:		20200721

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Afya Ltd
		CENTRAL INDEX KEY:			0001771007
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-EDUCATIONAL SERVICES [8200]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38992
		FILM NUMBER:		201037705

	BUSINESS ADDRESS:	
		STREET 1:		ALAMEDA OSCAR NIEMEYER, NO 119
		STREET 2:		SALA 504 VILA DA SERRA
		CITY:			NOVA LIMA, MINAS GERAIS
		STATE:			D5
		ZIP:			00000
		BUSINESS PHONE:		55 (31) 3515 7500

	MAIL ADDRESS:	
		STREET 1:		ALAMEDA OSCAR NIEMEYER, NO 119
		STREET 2:		SALA 504 VILA DA SERRA
		CITY:			NOVA LIMA, MINAS GERAIS
		STATE:			D5
		ZIP:			00000
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>afya20200721_6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>

<HTML>
<HEAD>
   <TITLE>afya20200721_6k.htm - Generated by SEC Publisher for SEC Filing</TITLE>
</HEAD>

<BODY bgcolor="#ffffff">



<P style="MARGIN: 0px">&nbsp;</P>

<DIV style="MARGIN-BOTTOM: 3pt; WIDTH: 100%; MARGIN-TOP: 12pt">

<DIV style="BORDER-TOP: black 2pt solid; BORDER-BOTTOM: black 1pt solid"><FONT style="FONT-SIZE: 1pt" face=times></FONT>&nbsp;</DIV></DIV>

<P style="TEXT-ALIGN: center; MARGIN: 0pt 0px"><FONT style="FONT-SIZE: 14pt" face=times></FONT>&nbsp;</P>

<P style="TEXT-ALIGN: center; MARGIN: 0pt 0px"><B><FONT style="FONT-SIZE: 14pt" face=times>UNITED STATES</FONT></B><FONT style="FONT-SIZE: 14pt" face=times>&nbsp;</FONT></P>

<P style="TEXT-ALIGN: center; MARGIN: 0pt 0px">&nbsp;</P>

<P style="TEXT-ALIGN: center; MARGIN: 0pt 0px"><B><FONT style="FONT-SIZE: 14pt" face=times>SECURITIES AND EXCHANGE COMMISSION</FONT></B></P>

<P style="TEXT-ALIGN: center; MARGIN: 0pt 0px">&nbsp;</P>

<P style="TEXT-ALIGN: center; MARGIN: 0pt 0px"><B><FONT style="FONT-SIZE: 14pt" face=times>Washington, D.C. 20549</FONT></B></P>

<P style="TEXT-ALIGN: center; MARGIN: 0pt 0px"><FONT style="FONT-SIZE: 14pt" face=times></FONT>&nbsp;</P>

<P style="TEXT-ALIGN: center; MARGIN: 0pt 0px"><B><FONT style="FONT-SIZE: 18pt" face=times>FORM 6-K</FONT></B></P>

<P style="TEXT-ALIGN: center; MARGIN: 0pt 0px"><FONT style="FONT-SIZE: 18pt" face=times></FONT>&nbsp;</P>

<P style="TEXT-ALIGN: center; MARGIN: 0pt 0px 0pt 6.85pt; TEXT-INDENT: -6.85pt"><B><FONT style="FONT-SIZE: 14pt" face=times>REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934</FONT></B></P>

<P style="TEXT-ALIGN: center; MARGIN: 0pt 0px 0pt 6.85pt; TEXT-INDENT: -6.85pt"><FONT style="FONT-SIZE: 14pt" face=times></FONT>&nbsp;</P>

<P style="TEXT-ALIGN: center; MARGIN: 0pt 0px"><FONT style="FONT-SIZE: 14pt" face=times>For the month of <FONT style="FONT-SIZE: 14pt" face="Times New Roman">July</FONT>, 2020</FONT></P>

<DIV style="MARGIN-BOTTOM: 3pt; WIDTH: 100%; MARGIN-TOP: 3pt">

<DIV style="BORDER-TOP: black 2pt solid"><FONT style="FONT-SIZE: 1pt" face=times></FONT>&nbsp;</DIV></DIV>

<P style="TEXT-ALIGN: center; MARGIN: 0pt 0px">&nbsp;</P>

<P style="TEXT-ALIGN: center; MARGIN: 0pt 0px"><FONT style="FONT-SIZE: 14pt" face=times>&nbsp;</FONT><FONT><B><FONT style="FONT-SIZE: 14pt" face=times>Commission File Number: 001</FONT></B></FONT><FONT style="FONT-SIZE: 14pt" face=times>-</FONT><FONT><B><FONT style="FONT-SIZE: 14pt" face=times>38992</FONT></B></FONT></P>

<P style="TEXT-ALIGN: center; MARGIN: 0pt 0px"><FONT style="FONT-SIZE: 12pt" face=times></FONT>&nbsp;</P>

<P style="TEXT-ALIGN: center; MARGIN: 0pt 0px"><B><FONT style="FONT-SIZE: 28pt" face=times>Afya Limited</FONT></B></P>

<P style="TEXT-ALIGN: center; MARGIN: 0pt 0px">&nbsp;</P>

<P style="TEXT-ALIGN: center; MARGIN: 0pt 0px"><B><FONT style="FONT-SIZE: 10pt" face=times>(Exact name of registrant as specified in its charter)</FONT></B></P>

<P style="TEXT-ALIGN: center; MARGIN: 0pt 0px"><FONT style="FONT-SIZE: 10pt" face=times></FONT>&nbsp;</P>

<P style="TEXT-ALIGN: center; MARGIN: 0pt 0px"><B><FONT style="FONT-SIZE: 12pt" face=times>Alameda Oscar Niemeyer, No.&nbsp;119, Salas 502, 504, 1,501 and 1,503</FONT></B></P>

<P style="TEXT-ALIGN: center; MARGIN: 0pt 0px">&nbsp;</P>

<P style="TEXT-ALIGN: center; MARGIN: 0pt 0px"><B><FONT style="FONT-SIZE: 12pt" face=times>Vila da Serra, Nova Lima, Minas Gerais</FONT></B></P>

<P style="TEXT-ALIGN: center; MARGIN: 0pt 0px">&nbsp;</P>

<P style="TEXT-ALIGN: center; MARGIN: 0pt 0px"><B><FONT style="FONT-SIZE: 12pt" face=times>Brazil</FONT></B></P>

<P style="TEXT-ALIGN: center; MARGIN: 0pt 0px">&nbsp;</P>

<P style="TEXT-ALIGN: center; MARGIN: 0pt 0px"><B><FONT style="FONT-SIZE: 12pt" face=times>+55 (31) 3515 7550</FONT></B></P>

<P style="TEXT-ALIGN: center; MARGIN: 0pt 0px">&nbsp;</P>

<P style="TEXT-ALIGN: center; MARGIN: 0pt 0px"><B><FONT style="FONT-SIZE: 10pt" face=times>(Address of principal executive office)</FONT></B></P>

<P style="TEXT-ALIGN: center; MARGIN: 0pt 0px"><FONT style="FONT-SIZE: 10pt" face=times></FONT>&nbsp;</P>

<P style="TEXT-ALIGN: center; MARGIN: 0pt 0px"><FONT style="FONT-SIZE: 10pt" face=times>Indicate by check mark whether the registrant files or will file annual reports under cover of Form&nbsp;20-F or Form 40-F:</FONT></P>

<P style="TEXT-ALIGN: center; MARGIN: 0pt 0px"><FONT style="FONT-SIZE: 10pt" face=times></FONT>&nbsp;</P>

<DIV align=center>

<TABLE style="WIDTH: 66%; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 border=0>



<TR>

   <TD style="TEXT-ALIGN: center"><FONT><FONT style="FONT-SIZE: 10pt; VERTICAL-ALIGN: top" face=times>Form 20-F</FONT></FONT></TD>

   <TD><FONT style="FONT-SIZE: 10pt; VERTICAL-ALIGN: top" face=times></FONT>

   <P style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: center; MARGIN: 0pt 0px"><FONT style="FONT-SIZE: 10pt; VERTICAL-ALIGN: top" face=times>X</FONT></P></TD>

   <TD style="TEXT-ALIGN: center"><FONT style="FONT-SIZE: 12pt; VERTICAL-ALIGN: top" face=times>&nbsp;</FONT></TD>

   <TD style="TEXT-ALIGN: center"><FONT><FONT style="FONT-SIZE: 10pt; VERTICAL-ALIGN: top" face=times>Form 40-F</FONT></FONT></TD>

   <TD style="BORDER-BOTTOM: black 1pt solid"><FONT style="FONT-SIZE: 10pt; VERTICAL-ALIGN: top" face=times>&nbsp;</FONT></TD></TR></TABLE></DIV>

<P style="TEXT-ALIGN: center; MARGIN: 0pt 0px"><FONT style="FONT-SIZE: 10pt" face=times></FONT>&nbsp;</P>

<P style="TEXT-ALIGN: center; MARGIN: 0pt 0px"><FONT style="FONT-SIZE: 10pt" face=times>Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation&nbsp;S-T&nbsp;Rule&nbsp;101(b)(1):</FONT></P>

<P style="TEXT-ALIGN: center; MARGIN: 0pt 0px"><FONT style="FONT-SIZE: 10pt" face=times></FONT>&nbsp;</P>

<DIV align=center>

<TABLE style="WIDTH: 66%; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 border=0>



<TR>

   <TD style="TEXT-ALIGN: center"><FONT><FONT style="FONT-SIZE: 10pt; VERTICAL-ALIGN: top" face=times>Yes</FONT></FONT></TD>

   <TD style="BORDER-BOTTOM: black 1pt solid"><FONT style="FONT-SIZE: 10pt; VERTICAL-ALIGN: top" face=times>&nbsp;</FONT></TD>

   <TD style="TEXT-ALIGN: center"><FONT style="FONT-SIZE: 12pt; VERTICAL-ALIGN: top" face=times>&nbsp;</FONT></TD>

   <TD style="TEXT-ALIGN: center"><FONT><FONT style="FONT-SIZE: 10pt; VERTICAL-ALIGN: top" face=times>No</FONT></FONT></TD>

   <TD><FONT style="FONT-SIZE: 10pt; VERTICAL-ALIGN: top" face=times></FONT>

   <P style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: center; MARGIN: 0pt 0px"><FONT style="FONT-SIZE: 10pt; VERTICAL-ALIGN: top" face=times>X</FONT></P></TD></TR></TABLE></DIV>

<P style="TEXT-ALIGN: center; MARGIN: 0pt 0px"><FONT style="FONT-SIZE: 10pt" face=times></FONT>&nbsp;</P>

<P style="TEXT-ALIGN: center; MARGIN: 0pt 0px"><FONT style="FONT-SIZE: 10pt" face=times>Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation&nbsp;S-T&nbsp;Rule&nbsp;101(b)(7):</FONT></P>

<P style="TEXT-ALIGN: center; MARGIN: 0pt 0px"><FONT style="FONT-SIZE: 10pt" face=times></FONT>&nbsp;</P>

<DIV align=center>

<TABLE style="WIDTH: 66%; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 border=0>



<TR>

   <TD style="TEXT-ALIGN: center"><FONT><FONT style="FONT-SIZE: 10pt; VERTICAL-ALIGN: top" face=times>Yes</FONT></FONT></TD>

   <TD style="BORDER-BOTTOM: black 1pt solid"><FONT style="FONT-SIZE: 10pt; VERTICAL-ALIGN: top" face=times>&nbsp;</FONT></TD>

   <TD style="TEXT-ALIGN: center"><FONT style="FONT-SIZE: 12pt; VERTICAL-ALIGN: top" face=times>&nbsp;</FONT></TD>

   <TD style="TEXT-ALIGN: center"><FONT><FONT style="FONT-SIZE: 10pt; VERTICAL-ALIGN: top" face=times>No</FONT></FONT></TD>

   <TD><FONT style="FONT-SIZE: 10pt; VERTICAL-ALIGN: top" face=times></FONT>

   <P style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: center; MARGIN: 0pt 0px"><FONT style="FONT-SIZE: 10pt; VERTICAL-ALIGN: top" face=times>X</FONT></P></TD></TR></TABLE></DIV>

<P style="TEXT-ALIGN: center; MARGIN: 0pt 0px"><FONT style="FONT-SIZE: 10pt" face=times></FONT>&nbsp;</P>

<P style="TEXT-ALIGN: center; MARGIN: 0pt 0px">&nbsp;</P>

<DIV style="MARGIN-BOTTOM: 12pt; WIDTH: 100%; MARGIN-TOP: 3pt">

<DIV style="BORDER-TOP: black 1pt solid; BORDER-BOTTOM: black 2pt solid"><FONT style="FONT-SIZE: 1pt" face=times></FONT>&nbsp;</DIV></DIV>

<P style="TEXT-ALIGN: center; MARGIN: 0pt 0px"><FONT style="FONT-SIZE: 10pt" face=times></FONT>&nbsp;</P>

<DIV style="MARGIN-BOTTOM: 6pt; MARGIN-TOP: 6pt; BORDER-BOTTOM: black 1pt solid">

<P style="MARGIN: 0pt"><FONT style="FONT-SIZE: 10pt" face=times></FONT>&nbsp;</P></DIV>



<DIV style="MARGIN-BOTTOM: 6pt; MARGIN-TOP: 6pt; PAGE-BREAK-BEFORE: always">

<P style="MARGIN: 0pt"><FONT style="FONT-SIZE: 10pt" face=times></FONT>&nbsp;</P></DIV>

<P style="TEXT-ALIGN: center; MARGIN: 0pt 0px"><B><FONT style="FONT-SIZE: 10pt" face=times>TABLE OF CONTENTS</FONT></B></P>

<P style="TEXT-ALIGN: center; MARGIN: 0pt 0px"><FONT style="FONT-SIZE: 10pt" face=times></FONT>&nbsp;</P>

<DIV align=left>

<TABLE style="WIDTH: 100%" cellSpacing=0 cellPadding=0 border=0>



<TR>

   <TD style="TEXT-ALIGN: center"><FONT><B><FONT style="FONT-SIZE: 10pt; VERTICAL-ALIGN: top" face=times>EXHIBIT</FONT></B></FONT></TD>

   <TD style="TEXT-ALIGN: center"><FONT style="FONT-SIZE: 12pt; VERTICAL-ALIGN: top" face=times>&nbsp;</FONT></TD></TR>

<TR>

   <TD style="TEXT-ALIGN: center"><FONT><FONT style="FONT-SIZE: 10pt; VERTICAL-ALIGN: top" face=times>
   <A href="exhibit99_1.htm">99.1 </A></FONT></FONT></TD>

   <TD><FONT><FONT style="FONT-SIZE: 10pt; VERTICAL-ALIGN: top" face=times>
   <A href="exhibit99_1.htm">Afya Limited Announces PEBMED&#8217;s Acquisition. </A></FONT></FONT></TD></TR></TABLE></DIV>

<P style="MARGIN: 0pt 0px"><FONT style="FONT-SIZE: 10pt" face=times><BR style="CLEAR: both"></FONT>&nbsp;</P>

<DIV style="MARGIN-BOTTOM: 6pt; MARGIN-TOP: 6pt; BORDER-BOTTOM: black 1pt solid">

<P style="MARGIN: 0pt"><FONT style="FONT-SIZE: 10pt" face=times></FONT>&nbsp;</P></DIV>



<DIV style="MARGIN-BOTTOM: 6pt; MARGIN-TOP: 6pt; PAGE-BREAK-BEFORE: always">

<P style="MARGIN: 0pt"><FONT style="FONT-SIZE: 10pt" face=times></FONT>&nbsp;</P></DIV>

<P style="MARGIN: 0pt 0px">&nbsp;</P>

<P style="MARGIN: 0pt 0px"><FONT style="FONT-SIZE: 10pt" face=times></FONT>&nbsp;</P>

<P style="TEXT-ALIGN: center; MARGIN: 0pt 0px"><B><FONT style="FONT-SIZE: 10pt" face=times>SIGNATURE</FONT></B></P>

<P style="TEXT-ALIGN: center; MARGIN: 0pt 0px"><FONT style="FONT-SIZE: 10pt" face=times></FONT>&nbsp;</P>

<P style="MARGIN: 0pt 0px; TEXT-INDENT: 0.25in"><FONT style="FONT-SIZE: 10pt" face=times>Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</FONT></P>

<P style="MARGIN: 0pt 0px; TEXT-INDENT: 0.25in"><FONT style="FONT-SIZE: 10pt" face=times></FONT>&nbsp;</P>

<DIV align=right>

<TABLE style="WIDTH: 40%; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 border=0>



<TR>

   <TD colSpan=2><FONT style="FONT-SIZE: 10pt; VERTICAL-ALIGN: top" face=times>&nbsp;</FONT></TD>

   <TD><FONT style="FONT-SIZE: 10pt; VERTICAL-ALIGN: top" face=times>&nbsp;</FONT></TD>

   <TD colSpan=3><FONT><B><FONT style="FONT-SIZE: 10pt; VERTICAL-ALIGN: top" face=times>Afya Limited</FONT></B></FONT></TD></TR>

<TR>

   <TD colSpan=2><FONT style="FONT-SIZE: 10pt; VERTICAL-ALIGN: top" face=times>&nbsp;</FONT></TD>

   <TD><FONT style="FONT-SIZE: 10pt; VERTICAL-ALIGN: top" face=times>&nbsp;</FONT></TD>

   <TD colSpan=3><FONT style="FONT-SIZE: 10pt; VERTICAL-ALIGN: top" face=times>&nbsp;</FONT></TD></TR>

<TR>

   <TD colSpan=2><FONT style="FONT-SIZE: 10pt; VERTICAL-ALIGN: top" face=times>&nbsp;</FONT></TD>

   <TD><FONT style="FONT-SIZE: 10pt; VERTICAL-ALIGN: top" face=times>&nbsp;</FONT></TD>

   <TD colSpan=3><FONT style="FONT-SIZE: 10pt; VERTICAL-ALIGN: top" face=times>&nbsp;</FONT></TD></TR>

<TR>

   <TD><FONT style="FONT-SIZE: 10pt; VERTICAL-ALIGN: top" face=times>&nbsp;</FONT></TD>

   <TD><FONT style="FONT-SIZE: 10pt; VERTICAL-ALIGN: top" face=times>&nbsp;</FONT></TD>

   <TD><FONT style="FONT-SIZE: 10pt; VERTICAL-ALIGN: top" face=times>&nbsp;</FONT></TD>

   <TD><FONT><FONT style="FONT-SIZE: 10pt; VERTICAL-ALIGN: top" face=times>By:</FONT></FONT></TD>

   <TD style="BORDER-BOTTOM: black 1pt solid" colSpan=2><FONT><FONT style="FONT-SIZE: 10pt; VERTICAL-ALIGN: top" face=times>/s/ Virgilio Deloy Capobianco Gibbon</FONT></FONT></TD></TR>

<TR>

   <TD><FONT style="FONT-SIZE: 10pt; VERTICAL-ALIGN: top" face=times>&nbsp;</FONT></TD>

   <TD><FONT style="FONT-SIZE: 10pt; VERTICAL-ALIGN: top" face=times>&nbsp;</FONT></TD>

   <TD><FONT style="FONT-SIZE: 10pt; VERTICAL-ALIGN: top" face=times>&nbsp;</FONT></TD>

   <TD><FONT style="FONT-SIZE: 10pt; VERTICAL-ALIGN: top" face=times>&nbsp;</FONT></TD>

   <TD><FONT><FONT style="FONT-SIZE: 10pt; VERTICAL-ALIGN: top" face=times>Name:</FONT></FONT></TD>

   <TD><FONT><FONT style="FONT-SIZE: 10pt; VERTICAL-ALIGN: top" face=times>Virgilio Deloy Capobianco Gibbon</FONT></FONT></TD></TR>

<TR>

   <TD><FONT style="FONT-SIZE: 10pt; VERTICAL-ALIGN: top" face=times>&nbsp;</FONT></TD>

   <TD><FONT style="FONT-SIZE: 10pt; VERTICAL-ALIGN: top" face=times>&nbsp;</FONT></TD>

   <TD><FONT style="FONT-SIZE: 10pt; VERTICAL-ALIGN: top" face=times>&nbsp;</FONT></TD>

   <TD><FONT style="FONT-SIZE: 10pt; VERTICAL-ALIGN: top" face=times>&nbsp;</FONT></TD>

   <TD><FONT><FONT style="FONT-SIZE: 10pt; VERTICAL-ALIGN: top" face=times>Title:</FONT></FONT></TD>

   <TD><FONT><FONT style="FONT-SIZE: 10pt; VERTICAL-ALIGN: top" face=times>Chief Executive Officer</FONT></FONT></TD></TR></TABLE></DIV>

<P style="TEXT-ALIGN: justify; MARGIN: 0pt 0px"><FONT style="FONT-SIZE: 10pt" face=times>Date:&nbsp;<FONT style="FONT-SIZE: 10pt" face="Times New Roman">July</FONT> 21, 2020</FONT></P>

<P style="TEXT-ALIGN: justify; MARGIN: 0pt 0px"><FONT style="FONT-SIZE: 10pt" face=times></FONT>&nbsp;</P>

<P style="MARGIN: 0px">&nbsp;</P>

<DIV style="MARGIN-BOTTOM: 3pt; WIDTH: 100%; MARGIN-TOP: 3pt">

<DIV style="BORDER-TOP: black 1pt solid"><FONT style="FONT-SIZE: 1pt" face=times></FONT>&nbsp;</DIV></DIV>

<P style="MARGIN: 0px">&nbsp;</P>

</BODY>

</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit99_1.htm
<DESCRIPTION>EX-99.1
<TEXT>

<HTML>
<HEAD>
   <TITLE>exhibit99_1.htm - Generated by SEC Publisher for SEC Filing</TITLE>
</HEAD>

<BODY bgcolor="#ffffff">

&nbsp; <A name="page_1"></A>

<a name="_bclPageBorder1"></a><DIV style="PADDING-LEFT: 0%; PADDING-RIGHT: 0%">

<P style="MARGIN: 0cm 0cm 0pt"><B><FONT lang=EN-US style="FONT-SIZE: 10pt" color=black face="times new roman">FOR IMMEDIATE RELEASE:</FONT></B></P>

<P style="MARGIN: 0cm 0cm 0pt"><B><FONT lang=EN-US style="FONT-SIZE: 10pt" color=black face="times new roman"></FONT></B>&nbsp;</P>

<P style="TEXT-ALIGN: center; MARGIN: 0cm 0cm 0pt" align=center>
<IMG border=0 src="header.jpg">&nbsp;</P>

<P style="TEXT-ALIGN: center; MARGIN: 0cm 0cm 0pt" align=center><B><I><FONT lang=EN-US style="FONT-SIZE: 10pt" color=black face="times new roman"></FONT></I></B>&nbsp;</P>

<P style="TEXT-ALIGN: center; MARGIN: 0cm 0cm 0pt" align=center><B><FONT lang=EN-US style="FONT-SIZE: 10pt" color=black face="times new roman">Afya Limited Announces PEBMED&#8217;s Acquisition</FONT></B></P>

<P style="TEXT-ALIGN: center; MARGIN: 0cm 0cm 0pt" align=center><B><I><FONT lang=EN-US style="FONT-SIZE: 10pt" color=black face="times new roman"></FONT></I></B>&nbsp;</P>

<P style="TEXT-ALIGN: center; MARGIN: 0cm 0cm 0pt" align=center><B><FONT lang=EN-US style="FONT-SIZE: 10pt" color=black face="times new roman"></FONT></B>&nbsp;</P>

<P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 10pt; TEXT-INDENT: 0cm"><B><FONT lang=EN-US style="FONT-SIZE: 10pt; LINE-HEIGHT: normal" color=black face="times new roman">July 21, 2020</FONT></B><FONT lang=EN-US style="FONT-SIZE: 10pt; LINE-HEIGHT: normal" color=black face="times new roman"> &#8211; Afya Limited, or Afya (Nasdaq: AFYA) today announced the acquisition of 100% of the total share capital of </FONT><I><FONT lang=EN-US style="FONT-SIZE: 10pt; LINE-HEIGHT: normal" color=black face="times new roman">PEBMED</FONT></I><FONT lang=EN-US style="FONT-SIZE: 10pt; LINE-HEIGHT: normal" color=black face="times new roman">, through its wholly-owned subsidiary Afya Participa&#231;&#245;es S.A.</FONT></P>

<P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 10pt; TEXT-INDENT: 0cm"><FONT lang=EN-US style="FONT-SIZE: 10pt; LINE-HEIGHT: normal" color=black face="times new roman">PEBMED offers content and clinical decision applications aiming a better performance of the healthcare professional, through its products:</FONT></P>

<P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt"><FONT lang=EN-US style="FONT-SIZE: 10pt" color=black face="times new roman"></FONT>&nbsp;</P>

<P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0cm 18pt; TEXT-INDENT: -18pt"><FONT lang=EN-US style="FONT-SIZE: 10pt" color=black face=symbol>&#183;</FONT><FONT lang=EN-US style="FONT-SIZE: 7pt" color=black face="times new roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT lang=EN-US style="FONT-SIZE: 10pt" color=black face="times new roman">WhiteBook: a mobile and web application software that helps doctors and medical students to make faster and more accurate clinical decisions on a daily practice. It provides medical calculators, images and updated content, including prescriptions, conducts, clinical scores, procedures, lab exams, and others, for more than 28 specialties. Whitebook&#8217;s revenue represents more than 95% of Pebmed&#8217;s total revenue and currently has 165,000 monthly active users. </FONT></P>

<P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt"><FONT lang=EN-US style="FONT-SIZE: 10pt" color=black face="times new roman"></FONT>&nbsp;</P>

<P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0cm 18pt; TEXT-INDENT: -18pt"><FONT lang=EN-US style="FONT-SIZE: 10pt" color=black face=symbol>&#183;</FONT><FONT lang=EN-US style="FONT-SIZE: 7pt" color=black face="times new roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT lang=EN-US style="FONT-SIZE: 10pt" color=black face="times new roman">Nursebook, a mobile application software that helps nurses to make accurate clinical decisions. This product also provides medical calculators, procedures and updated content software designed to help nurses all over Brazil. This product was launch on the third quarter of 2019 and currently has 20,000 monthly active users. </FONT></P>

<P style="MARGIN: 0cm 0cm 0cm 36pt"><FONT lang=EN-US style="FONT-SIZE: 10pt" color=black face="times new roman"></FONT>&nbsp;</P>

<P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0cm 18pt; TEXT-INDENT: -18pt"><FONT lang=EN-US style="FONT-SIZE: 10pt" color=black face=symbol>&#183;</FONT><FONT lang=EN-US style="FONT-SIZE: 7pt" color=black face="times new roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT lang=EN-US style="FONT-SIZE: 10pt" color=black face="times new roman">Portal Pebmed: a website that offers free references, perspectives and updates on medical news and scientific publications. The website has over 4,000,000 visitors per month and 900,000 returning visitors. &nbsp;</FONT></P>

<P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt"><FONT lang=EN-US style="FONT-SIZE: 10pt" color=black face="times new roman"></FONT>&nbsp;</P>

<P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt"><FONT lang=EN-US style="FONT-SIZE: 10pt" color=black face="times new roman">"With the integration of PEBMED to our platform, Afya will continue to expand our offerings for the medical professionals now focusing in the interaction with the patient," said Virg&#237;lio Gibbon, Afya&#8217;s CEO. &#8220;With this acquisition, Afya will strengthen its position in the medical career and expand our digital platform.&#8221;</FONT></P>

<P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt"><FONT lang=EN-US style="FONT-SIZE: 10pt" color=black face="times new roman"></FONT>&nbsp;</P>

<P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt"><FONT lang=EN-US style="FONT-SIZE: 10pt" color=black face="times new roman">"We founded PEBMED because we saw hundreds of doctors facing unprecedented circumstances and we wanted to help then in these difficult situations," said Bruno Lagoeiro, CEO of PEBMED. "Becoming part of the Afya platform will allow us to accelerate software development, reach more doctors and students across the country and fulfill our goal to help transform Brazilian health through the decisions that nurses and physicians make every day".</FONT></P>

<P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt"><FONT lang=EN-US style="FONT-SIZE: 10pt" color=black face="times new roman"></FONT>&nbsp;</P>

<P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 10pt; TEXT-INDENT: 0cm"><FONT lang=EN-US style="FONT-SIZE: 10pt; LINE-HEIGHT: normal" color=black face="times new roman">The acquisition will enable Afya to enter in a new business segment and will contribute for the development and expansion of Afya Digital increasing our monthly active users and bringing active physicians to our platform.</FONT></P>

<P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 10pt; TEXT-INDENT: 0cm"><FONT lang=EN-US style="FONT-SIZE: 10pt; LINE-HEIGHT: normal" color=black face="times new roman">The net purchase price was R$132.9 million, with the assumption of estimated net debt of R$7.1 million, of which: (i) 86.8% was paid in cash, and (ii) 13.2% was paid in Afya&#8217;s stock. The price multiple is equivalent to 4x Pebmed&#8217;s annual recurring revenue. </FONT></P>

<P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 10pt; TEXT-INDENT: 0cm"><FONT lang=EN-US style="FONT-SIZE: 10pt; LINE-HEIGHT: normal" color=black face="times new roman">Afya&#8217;s management team will host a conference call with investors June 21, 2020, 11:00 am EDT.</FONT></P>

<P style="MARGIN: 0cm 0cm 0pt"><FONT lang=EN-US style="FONT-SIZE: 10pt" color=black face="times new roman">Investors may listen to the conference call (ID: AFYA) by dialing +1 (844) 204-8942 or +1 (412)-717-9627 for US Numbers and (11) 3181-8565 for BR Numbers. A live and archived webcast of the call will be available on the Investor Relations section of the Company&#8217;s website at https://ir.afya.com.br/.&nbsp; </FONT></P>

<P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 10pt; TEXT-INDENT: 0cm"><FONT lang=EN-US style="FONT-SIZE: 10pt; LINE-HEIGHT: normal" color=black face="times new roman"></FONT>&nbsp;</P>

<P style="MARGIN: 0cm 0cm 0pt"><B><FONT lang=EN-US style="FONT-SIZE: 10pt" color=black face="times new roman">About Afya </FONT></B></P>

<P style="MARGIN: 0cm 0cm 0pt">&nbsp;</P>

<P style="MARGIN: 0cm 0cm 0pt"><FONT lang=EN-US style="FONT-SIZE: 10pt" color=black face="times new roman">Afya is a leading medical education group in Brazil based on number of medical school seats, delivering an end-to-end physician-centric ecosystem that serves and empowers students to be lifelong medical learners from the moment they join us as medical students through their medical residency preparation, graduation program, and continuing medical education activities. </FONT></P>

<P style="MARGIN: 0cm 0cm 0pt"><FONT lang=EN-US style="FONT-SIZE: 10pt" color=black face="times new roman"></FONT>&nbsp;</P>

<P style="MARGIN: 0cm 0cm 0pt"><B><FONT lang=EN-US style="FONT-SIZE: 10pt" color=black face="times new roman">Contact</FONT></B><FONT lang=EN-US style="FONT-SIZE: 10pt" color=black face="times new roman">: Investor Relations: ir@afya.com.br</FONT></P>

<P style="MARGIN: 0cm 0cm 0pt"><B><FONT lang=EN-US style="FONT-SIZE: 10pt" color=black face="times new roman"></FONT></B>&nbsp;</P></DIV>

<HR align=center SIZE=2 width="100%" noShade>



<DIV style="PAGE-BREAK-BEFORE: always">&nbsp;</DIV>



<P>&nbsp;</P>

</BODY>

</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>header.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 header.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!H17AI9@  34T *@    @ ! $:  4
M   !    /@$;  4    !    1@$H  ,    !  (   $Q  (    1    3@
M      !@     0   &     !<&%I;G0N;F5T(#0N,BXQ,@  _]L 0P " 0$!
M 0$" 0$! @(" @($ P(" @(%! 0#! 8%!@8&!08&!@<)" 8'"0<&!@@+" D*
M"@H*"@8("PP+"@P)"@H*_]L 0P$" @(" @(% P,%"@<&!PH*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*_\  $0@
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M7+13.+#^T+BZ,60)9O+=88]V0FW<,!GW5_C_ /\ !'3]I'_@GMX[\'_M%?\
M!-?QIXO\7ZC9ZHD>K:)-Y0N@H!DRYB$4<UHX4QR1L 1N7EMQV@'ZU> -=U7Q
M/X%T7Q+KOANYT>^U#2K>YO-'O"#-8RR1JSP.1P61B5..,K6M0 44 %% !10
M44 %% !10 44 %% !10!Q/[1GQI\,_L\?!#Q-\:?%KC[#X;TB:\DB\P*9W5?
MW<*D_P 4CE(U_P!IQ7Y!?\$O/^"AGQ&\-?\ !0"^\3?&C6?+TGXV:DRZR]QN
M2WBO&D=;.:+<>$23-J.<*C8).P47M8_J7P1\.Z/%'AAQ3C:D;U)TE2HZ:N=)
M?66EW;E"GHM;7/VQC8,@(/:G4'\M'Y/^"OD_X.>=='K9R?\ J,15^L '<B@
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MS'*;65&M4C'_  *3Y'\XV?S/R?\ "0V?\'/FLKZV4A^O_%+1U^L Z4'R(44
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M_8N^(EO\*OC+XNU)M=FL5NYK'1=+-TUI&Q^3S2" C, 2%Y.W!( 92>+\&?\
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M*N(<YQ'$6?8O-:_Q8BI.H_)SDY6^5['YV_\ !?[]E0>-?@KI?[5O@NQ\K7O
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MW2VM\ *1D%X3GY<%]C^BO"F4N&_"OBKB3:4Z5/!TWYUY6J6\XQ<)'ZZ*H48
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M'X5^#>EVT*WMG8K/KUQ&/^/K491ON)">XWDJO7"(BYP!3TN?T5QHO]6_H_\
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L% !10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %% !10!_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
